This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Article Abstract
Weight gain and the associated increased risk of diabetes and cardiovascular disease may be problems for individuals who receive long-term treatment with atypical antipsychotics. Atypical antipsychotics differ in their propensity to cause obesity and other metabolic disturbances. If a patient gains substantial weight while taking atypical antipsychotics, the physician should consider switching him or her to a drug with a lower risk of weight gain. The physician should also address patient lifestyle issues such as poor diet and lack of exercise.
/div>
This CME activity is expired. For more CME activities, visit cme.psychiatrist.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders
Vol 87 • 2026 • Number 3
Read the Current Issue
Original Research
Inhaled Mebufotenin (GH001) for Adult Patients with Postpartum Depression
Original Research
US Mortality Involving Obesity and Psychiatric Disorders
Academic Highlights
Treatment-Resistant Depression as a Dynamic Continuum: A Consensus Panel Report
Original Research
Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms
Original Research
Exposure-Based Video Therapy for OCD and PTSD
Original Research
Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress
Insightful. Evidence-based. Human-centered.
Listen Now